R. Lewis Dark
Articles by R. Lewis Dark
Two Forces Push for More FDA Oversight of LDTs
From the Volume XXX, No. 14 – October 2, 2023 Issue
CLINICAL AND GENETIC TESTING LABS MAY SUDDENLY FEEL THEMSELVES STUCK IN THE MIDDLE of a yin-yang situation when it comes to laboratory developed tests (LDTs). One force, the U.S. Food and Drug Administrati…
Is Lab and IVD Consolidation Ready to Hit the Wall?
From the Volume XXX, No. 13 – September 11, 2023 Issue
IN HUMAN HISTORY, ALL ERAS COME TO AN END. The majority of the time, the end of an era is disruptive and a new status quo emerges, with different winners and losers. Today, there is growing evidence that one era in c…
Provider Price Transparency Trend Has New Twist
From the Volume XXX, No. 12 – August 21, 2023 Issue
IT’S NOT JUST PATIENTS WHO ARE TYPICALLY UNABLE TO SEE PRICES FOR THEIR MEDICAL CARE IN ADVANCE OF SERVICE. Guess who else is unhappy that they cannot access the prices charged by hospitals, physicians, and other pro…
‘Virchow’ Is Your New Source of Managed Care Insights
From the Volume XXX, No. 11 – July 31, 2023 Issue
WE ARE UNVEILING A VALUABLE INTELLIGENCE RESOURCE FOR YOU. It is a new commentary focused exclusively on managed care contracting for diagnostic services provided by clinical laboratories and anatomic pathology gr…
Stressful Weeks Ahead for Labs Thanks to Z-codes
From the Volume XXX, No. 10 – July 10, 2023 Issue
We are not alone in recognizing that UnitedHealthcare’s…
Expect More Z-code Requirements for Genetic Tests
From the Volume XXX, No. 9 – June 19, 2023 Issue
GENETIC TESTING COMPANIES ARE STILL REACTING TO LAST MONTH’S NEWS that one of the nation’s largest health insurers—UnitedHealthcare (UHC)—will require Z-codes for molecular test claims submitte…
For Labs, a Little Angel and Devil Sit Behind Z-Codes
From the Volume XXX, No. 8 – May 30, 2023 Issue
Much lies underneath the surface of UnitedHealthcare’s (UHC) new policy mandating Z-code use for molecular tests covered under its commercial health plans. It’s a developme…
Healthcare Megatrends and a Famous Book
From the Volume XXX, No. 7 – May 8, 2023 Issue
PREDICTING THE FUTURE IS A RISKY BUSINESS. SKEPTICS ARE ALWAYS AROUND TO CALL ATTENTION TO PROPHETS WHO GET IT WRONG. One prophet whose predictions were on target was author John Naisbitt. Those of us around in…
What’s Next in 2023 for Clinical Laboratories?
From the Volume XXX, No. 6 – April 17, 2023 Issue
AS YOU OPEN THIS ISSUE OF THE DARK REPORT, in New Orleans, about 900 senior lab administrators, executives, and pathologists will be gathered at the 28th annual Executive War College on …
Come One, Come All to the Executive War College
From the Volume XXX, No. 5 – March 27, 2023 Issue
THIS IS FOR ALL OF YOU LONG-TIME READERS WHO EVERY SPRING SEE NEWS about the Executive War College on Diagnostics, Laboratory, and Pathology Management, tell yourself that you need to attend, but then you…
CURRENT ISSUE
Volume XXXI, No. 16 – November 25, 2024
Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized